Safety and Efficacy of HL Tablet in Non-alcoholic Fatty Liver Disease Patients

Summary

This study evaluates the safety and efficacy of HL tablet on reducing hepatic fat in non-alcoholic fatty liver disease patients. The patients are allocated to three groups; low dose, high dose, and placebo control group.

Timeline

Start

2013-11

Primary completion

2015-05

Completion

2015-05

Drugs

Indications